Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | caspase-7 (C14 family) | 0.009 | 0.4185 | 0.6354 |
Plasmodium falciparum | metacaspase 1 | 0.0047 | 0.1046 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0064 | 0.2275 | 0.2275 |
Echinococcus granulosus | caspase 2 | 0.009 | 0.4185 | 0.6354 |
Brugia malayi | hypothetical protein | 0.005 | 0.1309 | 0.2693 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1309 | 0.2693 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Plasmodium falciparum | metacaspase-like protein | 0.0047 | 0.1046 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.2341 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0064 | 0.2275 | 0.2275 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0043 | 0.0755 | 0.0755 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0064 | 0.2302 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0036 | 0.0249 | 0.0378 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0123 | 0.6586 | 1 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0047 | 0.1046 | 0.3935 |
Brugia malayi | polk-prov protein | 0.0039 | 0.0501 | 0.0639 |
Trichomonas vaginalis | FMN-dependent NADH-azoreductase, putative | 0.0043 | 0.0755 | 0.0755 |
Brugia malayi | Cell death protein 3 precursor | 0.009 | 0.4185 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma brucei | metacaspase | 0.0047 | 0.1046 | 0.3935 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Echinococcus granulosus | dna polymerase eta | 0.0036 | 0.0249 | 0.0378 |
Trypanosoma cruzi | arginine N-methyltransferase, putative | 0.005 | 0.1309 | 0.5231 |
Echinococcus multilocularis | caspase | 0.0123 | 0.6586 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma brucei | metacaspase MCA3 | 0.0047 | 0.1046 | 0.3935 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0815 | 0.1237 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0047 | 0.1046 | 0.1588 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0043 | 0.0815 | 0.1237 |
Trypanosoma brucei | Protein arginine N-methyltransferase 1 catalytic subunit | 0.005 | 0.1309 | 0.5231 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0039 | 0.0501 | 0.1241 |
Echinococcus granulosus | caspase | 0.0123 | 0.6586 | 1 |
Echinococcus multilocularis | caspase 2 | 0.009 | 0.4185 | 0.6354 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0064 | 0.2302 | 0.9835 |
Echinococcus multilocularis | Glutamate receptor, ionotropic kainate 3 | 0.0054 | 0.1551 | 0.2355 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Mycobacterium tuberculosis | Probable glutamine-binding lipoprotein GlnH (GLNBP) | 0.0039 | 0.0464 | 0.1026 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Echinococcus granulosus | caspase 3 | 0.0077 | 0.3216 | 0.4883 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.3495 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0065 | 0.2341 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0065 | 0.2341 | 1 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0043 | 0.0755 | 0.4778 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0171 | 1 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0064 | 0.2302 | 0.3495 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0171 | 1 | 1 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0047 | 0.1046 | 0.3935 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0047 | 0.1046 | 0.4545 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma cruzi | metacaspase, putative | 0.0047 | 0.1046 | 0.3935 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0043 | 0.0755 | 0.4778 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0043 | 0.0755 | 0.0755 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0047 | 0.1046 | 0.4545 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0036 | 0.0249 | 0.0378 |
Trypanosoma cruzi | metacaspase, putative | 0.0047 | 0.1046 | 0.3935 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0755 | 0.4778 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.1046 | 0.2025 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0057 | 0.1772 | 0.7519 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0065 | 0.2341 | 0.3554 |
Echinococcus granulosus | dna polymerase kappa | 0.0064 | 0.2275 | 0.3454 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0056 | 0.1752 | 0.3819 |
Schistosoma mansoni | DNA polymerase eta | 0.0036 | 0.0249 | 0.0378 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0815 | 0.1437 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.009 | 0.4185 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0043 | 0.0815 | 0.1237 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0123 | 0.6586 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0047 | 0.1046 | 0.4545 |
Entamoeba histolytica | hypothetical protein | 0.005 | 0.1309 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.0501 | 0.0639 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0064 | 0.2302 | 0.3495 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0054 | 0.1551 | 0.2355 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0065 | 0.2341 | 0.5315 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.9815 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0128 | 0.6921 | 0.6921 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.9794 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0043 | 0.0752 | 0.2403 |
Echinococcus multilocularis | dna polymerase kappa | 0.0064 | 0.2275 | 0.3454 |
Echinococcus multilocularis | caspase 3 | 0.0077 | 0.3216 | 0.4883 |
Trypanosoma cruzi | arginine N-methyltransferase, putative | 0.005 | 0.1309 | 0.5231 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Leishmania major | DNA polymerase eta, putative | 0.0036 | 0.0249 | 0.1064 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.9794 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0064 | 0.2275 | 0.9649 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Plasmodium vivax | hypothetical protein, conserved | 0.0047 | 0.1046 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Plasmodium vivax | metacaspase 1, putative | 0.0047 | 0.1046 | 1 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0047 | 0.1046 | 0.2025 |
Leishmania major | metacaspase, putative | 0.0047 | 0.1046 | 0.447 |
Trypanosoma brucei | Metacaspase-4 | 0.0047 | 0.1046 | 0.3935 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0171 | 1 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0047 | 0.1046 | 0.3935 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0047 | 0.1046 | 0.1046 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0043 | 0.0752 | 0.3211 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Chlamydia trachomatis | arginine ABC transporter substrate-binding protein ArtJ | 0.0039 | 0.0464 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Echinococcus multilocularis | caspase 8 | 0.0047 | 0.1046 | 0.1588 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0036 | 0.0249 | 0.0378 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma brucei | unspecified product | 0.0057 | 0.1772 | 0.7519 |
Trypanosoma cruzi | metacaspase, putative | 0.0047 | 0.1046 | 0.3935 |
Echinococcus multilocularis | dna polymerase eta | 0.0036 | 0.0249 | 0.0378 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0043 | 0.0752 | 0.2481 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0064 | 0.2275 | 0.9649 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.1046 | 0.1046 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein (hisJ) | 0.0039 | 0.0464 | 0.5 |
Trypanosoma brucei | metacaspase 5, putative | 0.0047 | 0.1046 | 0.3935 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.2341 | 0.3554 |
Treponema pallidum | amino acid ABC transporter, periplasmic binding protein | 0.0039 | 0.0464 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0815 | 0.1437 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0123 | 0.6586 | 1 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0064 | 0.2275 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0065 | 0.2341 | 1 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0054 | 0.1551 | 0.2355 |
Entamoeba histolytica | arginine N-methyltransferase protein, putative | 0.005 | 0.1309 | 1 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0123 | 0.6586 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.3495 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0039 | 0.0501 | 0.1241 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0043 | 0.0755 | 0.0755 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Loa Loa (eye worm) | hypothetical protein | 0.009 | 0.4185 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0036 | 0.0249 | 0.0378 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0064 | 0.2302 | 0.9794 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0065 | 0.2341 | 0.3554 |
Leishmania major | DNA polymerase kappa, putative | 0.0043 | 0.0752 | 0.3211 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trypanosoma brucei | metacaspase MCA2 | 0.0047 | 0.1046 | 0.3935 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Chlamydia trachomatis | glutamine binding protein | 0.0039 | 0.0464 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Echinococcus granulosus | caspase 8 | 0.0047 | 0.1046 | 0.1588 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0064 | 0.2275 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0043 | 0.0755 | 0.0755 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.